Domov › Obézita › North Carolina › Wilmington
Klinické štúdie Obézita v meste Wilmington, NC
15 štúdií pre Obézita hľadá účastníkov v zariadeniach v meste Wilmington a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Prebieha náborFáza 2
- Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Prebieha náborFáza 3
- Accellacare - Wilmington, Wilmington
- Jeffrey Coleman, OD, Wilmington
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Prebieha náborFáza 2
- TMA Headlands, Wilmington
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Prebieha náborFáza 3
- Accellacare and KDCILM, LLC, Wilmington
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Prebieha náborFáza 3
- Accellacare and KDCILM, LLC, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Prebieha náborFáza 3
- Accellacare - Wilmington - 1917 Tradd Court, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Prebieha náborFáza 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Prebieha náborFáza 3
- Accellacare of Wilmington, Wilmington
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Prebieha náborFáza 3
- KDCILM, LLC & Accellacare US, Inc., Wilmington
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Prebieha náborFáza 3
- Accellacare Research of Wilmington, Wilmington
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Prebieha náborFáza 3
- Accellacare Wilmington, Wilmington
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Prebieha náborFáza 3
- ACCOMPLISH-1 Research Site, Wilmington
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Prebieha náborFáza 2
- Accellacare of Wilmington, Wilmington
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Prebieha náborFáza 3
- Accellacare and KDCILM, LLC, Wilmington
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Prebieha náborFáza 1
- Accellacare, Wilmington
Štúdie Obézita v iných mestách
- Houston, TX43 štúdií
- Chicago, IL41 štúdií
- New York City, NY40 štúdií
- San Antonio, TX40 štúdií
- Washington, DC33 štúdií
- Orlando, FL32 štúdií
- Dallas, TX30 štúdií
- Boston, MA28 štúdií
- Las Vegas, NV27 štúdií
- Miami, FL27 štúdií
- Baltimore, MD26 štúdií
- Jacksonville, FL25 štúdií
Iné štúdie v Wilmington
- Nadváha11 štúdií
- Diabetes mellitus 2. typu8 štúdií
- Srdcové zlyhanie6 štúdií
- Ulcerózna kolitída4 štúdií
- Cholesterol3 štúdií
- Kardiovaskulárne ochorenia3 štúdií
- Vysoký krvný tlak3 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.